Christian O. Henry is the CEO of Pacific Biosciences of California, Inc. He has a strong background that blends science and business. He earned his B.A. in Biochemistry and Cell Biology from the University of California, San Diego, then furthered...

Current Market Cap

$505.22M

Number of Employees

796

Total Compensation

2020 - 2023

Trending up by 203.23% last year
Showing total compensation for the last 2020 - 2023

Stock

Up by 352.35% last year

Salary

Up by 5.02% last year

Bonus

Up by 86.61% last year

Other

Down by -72.89% last year

Year

2023

Total Compensation

$7.22M

Salary

$700.15K

Board Justification

The compensation philosophy is designed to align executive compensation with company performance, attract and retain key talent, and motivate executives to achieve short-term and long-term corporate objectives.

Bonus

$700.15K

Board Justification

The bonus is based on the achievement of certain pre-established performance criteria, including revenue and cash balance targets, with a payout of 100% of the target bonus opportunity due to meeting these goals in 2023.

Other

$15.29K

Board Justification

Other compensation includes travel and lodging costs covered by the Company for participation in a sales incentive trip.

Restricted Stock

$5.81M(594.69K RSU)

Board Justification

The stock awards consist of RSUs that vested in 2023, with the total number of shares vested being 594,687.

Performance Metrics

The performance metrics include revenue targets and cash balance goals, with specific thresholds for bonus payouts.

SEC Filing

From April 29, 2024

Christian O. Henry

CEO of Pacific Biosciences of California

P

Education

B.A. in Biochemistry and Cell Biology from the University of California, San Diego; M.B.A. with a concentration in finance from the University of California, Irvine.

Field of Expertise

Business & Management - Business

Born

Invalid Date - 0 years ago

Is Founder?

No

Current Tenure

4 years 2 months (Sep 2020 - Present)

Previous Experience

Executive Vice President & Chief Commercial Officer of Illumina, Inc.; various senior roles at Affymetrix, Inc., and Nektar Therapeutics.

View Holdings

Insider Holdings of Christian O. Henry

DNAILMN

$2.84M

-$11.54M (-80.26%)

Last Insider Trade

PACB

$172.69K

PACB at $1.75/share

Sep 16, 2024

Sale